Hwail Pharmaceutical Co.Ltd (061250) — Free Cash Flow Generation Index
Hwail Pharmaceutical Co.Ltd (061250) has a Free Cash Flow Generation Index of 0.80x as of September 2025. Free cash flow of ₩5.44 Billion represents 1% of operating cash flow (₩6.82 Billion). See 061250 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hwail Pharmaceutical Co.Ltd Free Cash Flow Generation Index (2011–2024)
Historical FCF Generation Index trend for Hwail Pharmaceutical Co.Ltd across 10 annual periods. Explore 061250 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Hwail Pharmaceutical Co.Ltd (2011–2024)
Year-by-year Free Cash Flow Generation Index for Hwail Pharmaceutical Co.Ltd. For the full company profile including market capitalisation, see Hwail Pharmaceutical Co.Ltd (061250) market capitalisation.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.98x | ₩-23.00 Billion | ₩11.63 Billion | ₩34.63 Billion | ▼ -382.1% |
| 2023 | 0.70x | ₩4.92 Billion | ₩7.02 Billion | ₩2.10 Billion | ▼ -20.1% |
| 2021 | 0.88x | ₩17.62 Billion | ₩20.09 Billion | ₩2.47 Billion | ▼ -32.2% |
| 2019 | 1.29x | ₩4.78 Billion | ₩3.69 Billion | ₩1.09 Billion | ▲ +6.4% |
| 2018 | 1.22x | ₩8.72 Billion | ₩7.17 Billion | ₩1.55 Billion | ▲ +14.6% |
| 2017 | 1.06x | ₩8.85 Billion | ₩8.34 Billion | ₩513.62 Million | ▲ +1.8% |
| 2016 | 1.04x | ₩9.99 Billion | ₩9.58 Billion | ₩413.00 Million | ▼ -55.0% |
| 2013 | 2.32x | ₩16.16 Billion | ₩6.97 Billion | ₩9.18 Billion | ▼ -73.3% |
| 2012 | 8.69x | ₩8.73 Billion | ₩1.00 Billion | ₩7.72 Billion | ▲ +417.8% |
| 2011 | 1.68x | ₩13.18 Billion | ₩7.86 Billion | ₩5.32 Billion | — |